Editorial: New approaches in the treatment of multiple myeloma: from target-based agents to the new era of microRNAs (dedicated to the memory of Prof. Salvatore Venuta)

Curr Cancer Drug Targets. 2012 Sep;12(7):741-2. doi: 10.2174/156800912802429328.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Clinical Trials as Topic
  • Drug Evaluation, Preclinical
  • Humans
  • MicroRNAs / therapeutic use*
  • Molecular Targeted Therapy / methods*
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / genetics
  • Multiple Myeloma / therapy*

Substances

  • MicroRNAs